Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Envisia Therapeutics Inc.
DescriptionSustained-release anti-VEGF mAb
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today